Assignee
AKEBIA THERAPEUTICS INC
US·29 granted patents·23 pending applications·309 citations·filing 2010–2025
Top patents by PatentIndex Score
52 records- 0197US11426393B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2020·Granted Aug 30, 2022·5 cites·7 claims
- 0297US11065237B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2020·Granted Jul 20, 2021·8 cites·18 claims
- 0397US10149842B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2018·Granted Dec 11, 2018·15 cites·20 claims
- 0497US9987262B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2017·Granted Jun 5, 2018·18 cites·15 claims
- 0597US9598370B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2015·Granted Mar 21, 2017·26 cites·8 claims
- 0697US8343952B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2010·Granted Jan 1, 2013·36 cites·32 claims
- 0796US11883386B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2022·Granted Jan 30, 2024·2 cites·5 claims
- 0896US11267785B2Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amidesAKEBIA THERAPEUTICS INC·Filed 2020·Granted Mar 8, 2022·5 cites·5 claims
- 0996US10738010B2Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amidesAKEBIA THERAPEUTICS INC·Filed 2019·Granted Aug 11, 2020·12 cites·15 claims
- 1096US10596158B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·12 cites·19 claims
- 1196US9701636B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2014·Granted Jul 11, 2017·23 cites·11 claims
- 1296US8940773B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2013·Granted Jan 27, 2015·27 cites·10 claims
- 1396US8598210B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2012·Granted Dec 3, 2013·31 cites·8 claims
- 1495US10729681B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2018·Granted Aug 4, 2020·11 cites·5 claims
- 1595US9776969B2Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amidesAKEBIA THERAPEUTICS INC·Filed 2015·Granted Oct 3, 2017·22 cites·4 claims
- 1695US8722895B2Prolyl hydroxylase inhibitors and method of useAKEBIA THERAPEUTICS INC·Filed 2013·Granted May 13, 2014·27 cites·17 claims
- 1794US11690836B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·2 cites·23 claims
- 1894USRE47437EProlyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2018·Granted Jun 18, 2019·7 cites·8 claims
- 1992US10246416B2Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amidesAKEBIA THERAPEUTICS INC·Filed 2017·Granted Apr 2, 2019·11 cites·9 claims
- 2090US12478615B2Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2023·Granted Nov 25, 2025·0 cites·8 claims
- 2188US11713298B2Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acidAKEBIA THERAPEUTICS INC·Filed 2019·Granted Aug 1, 2023·2 cites·17 claims
- 2286US12419877B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2023·Granted Sep 23, 2025·0 cites·20 claims
- 2386US10150734B2Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereofAKEBIA THERAPEUTICS INC·Filed 2016·Granted Dec 11, 2018·6 cites·17 claims
- 2477US2023002323A1Process for preparing [(3-hydroxypyridine-2-carbonyl)amino]alkanoic acids, esters and amidesAKEBIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2576US12269802B2Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino] acetic acidAKEBIA THERAPEUTICS INC·Filed 2023·Granted Apr 8, 2025·0 cites·17 claims
- 2674US2025352527A1Methods for treating viral infections, organ injury, and related conditionsAKEBIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2771US12569474B2Compositions and methods for treating anemiaAKEBIA THERAPEUTICS INC·Filed 2023·Granted Mar 10, 2026·0 cites·16 claims
- 2871US2024325361A1Compositions and Methods for Treating AnemiaAKEBIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2970US2023144457A1Methods for treating viral infections, organ injury, and related conditionsAKEBIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3069US11857543B2Compositions and methods for treating anemiaAKEBIA THERAPEUTICS INC·Filed 2014·Granted Jan 2, 2024·1 cites·30 claims
- 3169US2015119425A1Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 3268US11844756B2Compositions and methods for treating anemiaAKEBIA THERAPEUTICS INC·Filed 2022·Granted Dec 19, 2023·0 cites·18 claims
- 3367US2024336568A1Selective phd1 inhibitor compounds, compositions, and methods of useAKEBIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3467US2014057892A1Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 3567US2017189387A1Prolyl hydroxylase inhibitors and methods of useAKEBIA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3667US2024327376A1Picolinamide compounds as selective phd1 inhibitors, compositions, and methods of useAKEBIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3765US2025243164A1Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acidAKEBIA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3859US2024325360A1Therapeutic methods using vadadustatAKEBIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3959US2024148707A1Modulation of drug-drug interactions of vadadustatAKEBIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4057US2023263786A1Modulation of drug-drug interactions of vadadustatAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4155US11324734B2Compositions and methods for treating anemiaAKEBIA THERAPEUTICS INC·Filed 2016·Granted May 10, 2022·0 cites·8 claims
- 4255US2023218592A1Treatment of viral infections, of organ injury, and of related conditions using a hif prolyl hydroxylase inhibitor or a hif-alpha stabilizerAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4354US2023285374A1Therapeutic methods using vadadustatAKEBIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4454US2021369678A1Benzimidazole derivative for use in the treatment of inflammatory disordersAKEBIA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4550US2023295110A1Phd inhibitor compounds, compositions, and methods of useAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4650US2023286918A1Manufacturing process for 3,5-dichloropicolinonitrile for synthesis of vadadustatAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4749US2023159489A1Phd inhibitor compounds, compositions, and useAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4848US2023227426A1Phd inhibitor compounds, compositions, and useAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4947US2023212138A1Phd inhibitor compounds, compositions, and their useAKEBIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 5045US11524939B2Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acidAKEBIA THERAPEUTICS INC·Filed 2020·Granted Dec 13, 2022·0 cites·20 claims
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when AKEBIA THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →